Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway*

Regulation of intracellular cyclic adenosine 3 ′,5 ′-monophosphate (cAMP) is integral in mediating cell growth, cell differentiation, and immune responses in hematopoietic cells. To facilitate studies of cAMP regulation we developed a BRET (bioluminescence resonance energy transfer) sensor for cAMP, CAMYEL (cAMP sensor using YFP-Epac-RLuc), which can quantitatively and rapidly monitor intracellular concentrations of cAMP in vivo. This sensor was used to characterize three distinct pathways for modulation of cAMP synthesis stimulated by presumed Gs-dependent receptors for isoproterenol and prostaglandin E2. Whereas two ligands, uridine 5 ′-diphosphate and complement C5a, appear to use known mechanisms for augmentation of cAMP via Gq/calcium and Gi, the action of sphingosine 1-phosphate (S1P) is novel. In these cells, S1P, a biologically active lysophospholipid, greatly enhances increases in intracellular cAMP triggered by the ligands for Gs-coupled receptors while having only a minimal effect by itself. The enhancement of cAMP by S1P is resistant to pertussis toxin and independent of intracellular calcium. Studies with RNAi and chemical perturbations demonstrate that the effect of S1P is mediated by the S1P2 receptor and the heterotrimeric G13 protein. Thus in these macrophage cells, all four major classes of G proteins can regulate intracellular cAMP.

[1]  T. Hla,et al.  Differential Pharmacological Properties and Signal Transduction of the Sphingosine 1-Phosphate Receptors EDG-1, EDG-3, and EDG-5* , 1999, The Journal of Biological Chemistry.

[2]  G. Baillie,et al.  The MAP kinase ERK2 inhibits the cyclic AMP‐specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 , 1999, The EMBO journal.

[3]  G. Baillie,et al.  ERK2 Mitogen-activated Protein Kinase Binding, Phosphorylation, and Regulation of the PDE4D cAMP-specific Phosphodiesterases , 2000, The Journal of Biological Chemistry.

[4]  A. Wittinghofer,et al.  Structure and regulation of the cAMP-binding domains of Epac2 , 2003, Nature Structural Biology.

[5]  M. Conti,et al.  Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase , 1995, The Journal of Biological Chemistry.

[6]  V. Sah,et al.  The role of Rho in G protein-coupled receptor signal transduction. , 2000, Annual review of pharmacology and toxicology.

[7]  G. Milligan,et al.  Tailoring cAMP-signalling responses through isoform multiplicity. , 1997, Trends in biochemical sciences.

[8]  S. Kimura,et al.  The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. , 1999, The Biochemical journal.

[9]  E. Goetzl,et al.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network , 2005, Nature Reviews Immunology.

[10]  J. Bos Epac: a new cAMP target and new avenues in cAMP research , 2003, Nature Reviews Molecular Cell Biology.

[11]  D. Manning,et al.  Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. , 2002, Biochimica et biophysica acta.

[12]  L. Brass,et al.  Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties. , 1992, The Biochemical journal.

[13]  J. Beavo,et al.  Cyclic nucleotide research — still expanding after half a century , 2002, Nature Reviews Molecular Cell Biology.

[14]  Xiaodong Cheng,et al.  Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Thomas A Luger,et al.  Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.

[16]  G. Johnson,et al.  Gα12 and Gα13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly (*) , 1995, The Journal of Biological Chemistry.

[17]  A. Gilman,et al.  Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. , 1991, Science.

[18]  T. Ishizuka,et al.  Comparison of Intrinsic Activities of the Putative Sphingosine 1-Phosphate Receptor Subtypes to Regulate Several Signaling Pathways in Their cDNA-transfected Chinese Hamster Ovary Cells* , 1999, The Journal of Biological Chemistry.

[19]  R. Tsien,et al.  Reducing the Environmental Sensitivity of Yellow Fluorescent Protein , 2001, The Journal of Biological Chemistry.

[20]  D. Storm,et al.  Calmodulin-regulated adenylyl cyclases: cross-talk and plasticity in the central nervous system. , 2003, Molecular pharmacology.

[21]  Y. Yatomi,et al.  EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition* , 1998, The Journal of Biological Chemistry.

[22]  A. Miyawaki,et al.  Expanded dynamic range of fluorescent indicators for Ca(2+) by circularly permuted yellow fluorescent proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Bristow,et al.  Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. , 2005, Current topics in developmental biology.

[24]  Madhusudan Natarajan,et al.  A global analysis of cross-talk in a mammalian cellular signalling network , 2006, Nature Cell Biology.

[25]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[26]  P. Epstein,et al.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. , 2006, The Biochemical journal.

[27]  S. Pyne,et al.  Sphingosine 1-phosphate signalling in mammalian cells , 2000 .

[28]  A. Lania,et al.  G protein mutations in endocrine diseases. , 2001, European journal of endocrinology.

[29]  Martin J. Lohse,et al.  Novel Single Chain cAMP Sensors for Receptor-induced Signal Propagation*♦ , 2004, Journal of Biological Chemistry.

[30]  J. T. Turner,et al.  Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL. , 1992, The Journal of pharmacology and experimental therapeutics.

[31]  A. Barr,et al.  Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins* , 1999, The Journal of Biological Chemistry.

[32]  Weng-Lang Yang,et al.  Reinventing the Wheel of Cyclic AMP , 2002 .

[33]  J. Hanoune,et al.  Regulation and role of adenylyl cyclase isoforms. , 2001, Annual review of pharmacology and toxicology.

[34]  K. Baltensperger,et al.  Thrombin and phorbol esters potentiate Gs-mediated cAMP formation in intact human erythroid progenitors via two synergistic signaling pathways converging on adenylyl cyclase type VII. , 1998, Molecular pharmacology.

[35]  T. Issad,et al.  The use of resonance energy transfer in high-throughput screening: BRET versus FRET. , 2002, Trends in pharmacological sciences.

[36]  R. T. Miller,et al.  Purification and characterization of the alpha subunit of G13. , 1994, The Journal of biological chemistry.

[37]  R. Sunahara,et al.  Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. , 2002, Molecular interventions.

[38]  A. Sahu,et al.  A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding , 2002, Nature Neuroscience.

[39]  Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors , 2005, Medicinal research reviews.

[40]  T. Ohmori,et al.  Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. , 2002, Biochemical and biophysical research communications.

[41]  Kees Jalink,et al.  Detecting cAMP‐induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator , 2004, EMBO reports.

[42]  R. Stoffel,et al.  A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits. , 1995, Science.

[43]  A. Wittinghofer,et al.  Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state , 2006, Nature.

[44]  Ian McPhee,et al.  Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1) , 2002, British journal of pharmacology.

[45]  T. Bleu,et al.  Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5* , 2000, The Journal of Biological Chemistry.

[46]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[47]  Susan S. Taylor,et al.  A genetically encoded, fluorescent indicator for cyclic AMP in living cells , 1999, Nature Cell Biology.